There is increasing evidence to suggest that limited expansion of CAR T-cells and reduced durable response rates are linked to increased interferon signaling, which upregulates PD-L1 on tumor cells in the TME and on circulating MDSCs (47). Here, CD274 is linked to neoplasm.